本文采用辐射胶片结合指形电离室的测量方法,借鉴AAPM 51号报告的电离室测量方法和AAM P 55报告中对放射治疗计划系统验证的推荐标准,对本实验室新研发的H W-Plan放射治疗计划系统进行了实验验证,内容包括点剂量、轴向剂量分布曲线以及...本文采用辐射胶片结合指形电离室的测量方法,借鉴AAPM 51号报告的电离室测量方法和AAM P 55报告中对放射治疗计划系统验证的推荐标准,对本实验室新研发的H W-Plan放射治疗计划系统进行了实验验证,内容包括点剂量、轴向剂量分布曲线以及等剂量曲线的验证比较。实验采用方形水模和有机玻璃模体,通过CT扫描确定模体的电子密度和模拟靶点(测量位置),采用PTW电离室测量在三野交叉共面、等中心照射条件下等中心点和偏等中心点的照射剂量,采用K odak ED R2辐射胶片测量该条件下靶区剂量场的相对分布,并与计划系统在相同照射条件下计算的剂量场进行了验证比较,实现了对H W-Plan放射治疗计划系统验证,为计划系统的市场准入和进入临床应用提供了可靠的依据。展开更多
The aim of the present investigation is to determine initial G2-chromosome aberrations and to validate whether the G2-chromosome aberrations can predict the cellular clonogenic survival in human tumor cell lines. Cell...The aim of the present investigation is to determine initial G2-chromosome aberrations and to validate whether the G2-chromosome aberrations can predict the cellular clonogenic survival in human tumor cell lines. Cell lines of human ovary carcinoma cells (HO8910) and human hepatoma cells (HepG2) were irradiated with a range of doses and assessed both for initial G2-chromosome aberrations and for cell survival after γ -irradiation. The initial G2-chromosome aberrations were measured by counting the number of G2-chromatid breaks after irradiation, detected by the premature chromosome condensation technique, and the G2-assay method. Cell survival was documented by a colony formation assay. A linear-quadratic survival curve was observed in both cell lines. The dose–response results show that the numbers of G2-chromatid breaks increase with the increase in dose in the two cell lines. At higher doses (higher than 4 Gy) of irradiation, the number of G2-chromatid breaks for the G2-assay method cannot be determined because too few cells reach mitosis, and hence their detection is difficult. A good correlation is found between the clonogenic survival and the radiation-induced initial G2-chromatid breaks per cell (r = 0.9616). The present results suggest that the premature chromosome condensation technique may be useful for determining chromatid breaks in G2 cells, and the number of initial G2-chromatid breaks holds promise for predicting the radiosensitivity of tumor cells.展开更多
文摘本文采用辐射胶片结合指形电离室的测量方法,借鉴AAPM 51号报告的电离室测量方法和AAM P 55报告中对放射治疗计划系统验证的推荐标准,对本实验室新研发的H W-Plan放射治疗计划系统进行了实验验证,内容包括点剂量、轴向剂量分布曲线以及等剂量曲线的验证比较。实验采用方形水模和有机玻璃模体,通过CT扫描确定模体的电子密度和模拟靶点(测量位置),采用PTW电离室测量在三野交叉共面、等中心照射条件下等中心点和偏等中心点的照射剂量,采用K odak ED R2辐射胶片测量该条件下靶区剂量场的相对分布,并与计划系统在相同照射条件下计算的剂量场进行了验证比较,实现了对H W-Plan放射治疗计划系统验证,为计划系统的市场准入和进入临床应用提供了可靠的依据。
基金Supported by the Key Project (10335050) of National Natural Science Foundation of China and the Dedicated Project (2003CCB00200) of Science and Technology Ministry of China.
文摘The aim of the present investigation is to determine initial G2-chromosome aberrations and to validate whether the G2-chromosome aberrations can predict the cellular clonogenic survival in human tumor cell lines. Cell lines of human ovary carcinoma cells (HO8910) and human hepatoma cells (HepG2) were irradiated with a range of doses and assessed both for initial G2-chromosome aberrations and for cell survival after γ -irradiation. The initial G2-chromosome aberrations were measured by counting the number of G2-chromatid breaks after irradiation, detected by the premature chromosome condensation technique, and the G2-assay method. Cell survival was documented by a colony formation assay. A linear-quadratic survival curve was observed in both cell lines. The dose–response results show that the numbers of G2-chromatid breaks increase with the increase in dose in the two cell lines. At higher doses (higher than 4 Gy) of irradiation, the number of G2-chromatid breaks for the G2-assay method cannot be determined because too few cells reach mitosis, and hence their detection is difficult. A good correlation is found between the clonogenic survival and the radiation-induced initial G2-chromatid breaks per cell (r = 0.9616). The present results suggest that the premature chromosome condensation technique may be useful for determining chromatid breaks in G2 cells, and the number of initial G2-chromatid breaks holds promise for predicting the radiosensitivity of tumor cells.
